Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AARD
Stock Latest News
Pre-Earnings
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
18h ago
AARD
Premium
The Fly
Aardvark Therapeutics price target lowered to $8 from $32 at B. Riley
12d ago
AARD
Premium
Company Announcements
Aardvark Therapeutics Establishes $150 Million Equity Program
12d ago
8K
AARD
Premium
Ratings
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
12d ago
AARD
Premium
The Fly
Closing Bell Movers: Core Labs falls after below-consensus pre-announcement
12d ago
APO
CLB
Premium
The Fly
Aardvark Therapeutics files $400M mixed securities shelf
12d ago
AARD
Premium
The Fly
Aardvark Therapeutics reports Q4 EPS (81c), consensus (83c)
12d ago
AARD
Premium
Company Announcements
Aardvark’s ARD-101 Prader-Willi Study Suspended: What Investors Should Watch Next
16d ago
AARD
Premium
Company Announcements
Aardvark’s HERO Extension Trial Paused: What ARD-101’s Status Means for Investors
16d ago
AARD
Premium
Market News
Morning News Wrap-Up 3/2/26: Monday’s Biggest Stock Market Stories!
1M ago
HD
MU
Premium
The Fly
Aardvark Therapeutics price target lowered to $45 from $50 at Cantor Fitzgerald
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics price target lowered to $9 from $26 at BTIG
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics price target lowered to $21 from $35 at Oppenheimer
1M ago
AARD
Premium
Market News
Why Is Aardvark Therapeutics Stock (AARD) Down Today?
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
AARD
Premium
The Fly
Aardvark downgraded to Equal Weight from Overweight at Morgan Stanley
1M ago
AARD
Premium
The Fly
Aardvark downgraded to Sector Perform from Outperform at RBC Capital
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics downgraded to Hold from Buy at Stifel
1M ago
AARD
Premium
Company Announcements
Aardvark Pauses ARD-101 Phase 3 HERO Trial Enrollment
1M ago
8K
AARD
Premium
The Fly
Aardvark Therapeutics down 54% to $5.70 after pausing Phase 3 HERO trial
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics Inc trading resumes
1M ago
AARD
Premium
The Fly
Aardvark Therapeutics voluntarily pauses Phase 3 HERO trial
1M ago
AARD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
